FIELD: chemistry.
SUBSTANCE: present invention relates to use of maltose monohydrate in final concentration in the ready solution of 1-10 wt.% as an auxiliary substance in a combined preparation based on the active substances of tiletamine hydrochloride and zolazepam hydrochloride.
EFFECT: present invention provides the use of maltose monohydrate as an auxiliary substance in a complex preparation of tyletamine hydrochloride and zolazepam hydrochloride, which will help not only protect this pharmaceutical substance during lyophilisation from hypothermia, preserve structural stability and activity, but also become an additional source of energy for the animal in the postoperative period.
1 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ANAESTHETISATION IN RATS AT STAGED EXPERIMENT IN SIMULATED ENDOMETRIOSIS | 2011 |
|
RU2466753C1 |
| METHOD FOR HUMANE EUTHANASIA OF LABORATORY ANIMALS IN EXPERIMENT | 2024 |
|
RU2836552C1 |
| ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA | 2018 |
|
RU2691938C1 |
| TIGECYCLINE COMPOSITION AND METHODS FOR PREPARING | 2006 |
|
RU2428190C2 |
| METHOD FOR PREPARING MEDICINAL AGENT CONTAINING VARDENAFIL HYDROCHLORIDE TRIHYDRATE | 2008 |
|
RU2493849C2 |
| BIOLOGIALLY ACTIVE AGENT HAVING EFFECT ON GENERAL METABOLIC, EXCITATORY AND INHIBITORY NERVE FUNCTION AND INTELLECTUAL MNESTIC CEREBRAL FUNCTIONS (VERSIONS) | 2011 |
|
RU2461374C1 |
| PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS EUTHANASIA OF ANIMALS BY HUMANE METHOD | 2024 |
|
RU2840669C1 |
| MEANS FOR ISCHEMIA TREATMENT, METHOD FOR ITS PRODUCTION AND METHOD FOR ISCHEMIA TREATMENT (VERSIONS) | 2015 |
|
RU2620163C2 |
| DETERMINATION OF CARBOHYDRATE STABILIZERS IN BIOLOGICALLY ACTIVE PREPARATIONS | 2023 |
|
RU2816030C1 |
| MEDICINE CONTAINING SODIUM PENTOZANPOLISULPHATE FOR USE IN THE TREATMENT OF THE OBSTRUCTION OF THE BLADDER AND/OR SYMPTOMS OF THE LOWER URINARY TRACT | 2016 |
|
RU2680098C1 |
